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Abstract
Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Food and Food
Allergens (NDA) was asked to deliver an opinion on the safety of frozen and dried formulations from
migratory locust (Locusta migratoria) as a novel food pursuant to Regulation (EU) 2015/2283. The
term migratory locust refers to the adult of the insect species Locusta migratoria. The NF is proposed
in three formulations i) frozen without legs and wings; ii) dried without legs and wings; iii) ground with
legs and wings. The main components of the NF are protein, fat and fibre (chitin) in the dried form of
the NF, and water, protein, fat and fibre (chitin) in the frozen form of the NF. The Panel notes that the
concentration of contaminants in the NF depends on the occurrence levels of these substances in
the insect feed. The Panel notes that there are no safety concerns regarding the stability of the NF if
the NF complies with the proposed specification limits during its entire shelf-life. The NF has a high
protein content, although the true protein levels in the NF are overestimated when using the nitrogen-
to-protein conversion factor of 6.25, due to the presence of non-protein nitrogen from chitin. The
applicant proposed to use the NF as frozen, dried and ground in the form of snack, and as a food
ingredient in a number of food products. The target population proposed by the applicant is the
general population. The Panel notes that considering the composition of the NF and the proposed
conditions of use, the consumption of the NF is not nutritionally disadvantageous. The submitted
history of use and toxicity studies from literature did not raise safety concerns. The Panel considers
that the consumption of the NF might trigger primary sensitisation to L. migratoria proteins and may
cause allergic reactions in subjects with allergy to crustaceans, mites and molluscs. Additionally,
allergens from the feed may end up in the NF. The Panel concludes that the NF is safe under the
proposed uses and use levels.
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1. Introduction
1.1. Background and Terms of Reference as provided by the requestor
On 28 December 2018, the company Fair Insects BV (A Protix Company) submitted a request to
the European Commission in accordance with Article 10 of Regulation (EU) 2015/2283 to authorize
placing on the market of whole and ground grasshoppers (Locusta migratoria) as a novel food.
The target population is general population, excluding infants and young children. The applicant
has also requested data protection under Article 26 of Regulation (EU) 2015/2283.
In accordance with Article 10(3) of Regulation (EU) 2015/2283, the European Commission asks the
European Food Safety Authority to provide a scientific opinion on the safety of whole and ground
grasshoppers (Locusta migratoria) as a novel food.
The European Commission asks the European Food Safety Authority to evaluate and inform the
Commission as to whether and if so, to what extent, the requirements of Article 26(2)(c) of Regulation
(EU) 2015/2283 are fulfilled in elaborating its opinion on whole and ground grasshoppers (Locusta
migratoria) regarding the proprietary data for which the applicant is requesting data protection.
In the process of the evaluation of this Novel Food, it became apparent that the Commission should
amend the title of the mandate in relation to the terms “whole” and “grasshopper”. The term
“grasshopper” is generic and does not exclusively refer to Locusta migratoria, and the term “whole” is
not accurate as some of the parts may need to be removed prior to its consumption. On that basis,
the Commission amended the title to “Revised request for a scientific opinion on frozen and dried
formulations from migratory locust (Locusta migratoria) as a novel food”.
1.2. Interpretation of the Terms of Reference
Given the proposed intended uses and in accordance to Art 5 of the Commission Implementing
Regulation (EU) 2017/2469 stating ‘where it cannot be excluded that a novel food intended for a
particular group of the population would be also consumed by other groups of the population, the
safety data provided shall also cover those groups’, it was clarified that the target population is the
general population.
The applicant was requested to provide a revised assessment for the anticipated intake considering
all population groups.
2. Data and methodologies
2.1. Data
The safety assessment of this NF is based on data supplied in the application and information
submitted by the applicant following EFSA’s requests for supplementary information. Additional
information, which was not included in the application, was retrieved by literature search following a
search strategy and standard operating procedure as described by UCT Prague (2020).
Administrative and scientific requirements for NF applications referred to in Article 10 of Regulation
(EU) 2015/2283 are listed in the Commission Implementing Regulation (EU) 2017/24691.
A common and structured format on the presentation of NF applications is described in the EFSA
guidance on the preparation and presentation of an NF application (EFSA NDA Panel, 2016). As
indicated in this guidance, it is the duty of the applicant to provide all of the available (proprietary,
confidential and published) scientific data (including both data in favour and not in favour) that are
pertinent to the safety of the NF.
This NF application includes a request for protection of proprietary data in accordance with Article
26 of Regulation (EU) 2015/2283. The data requested by the applicant to be protected comprise
description of the production process, analytical data on the composition of the NF, analytical data on
contaminants in the NF, stability and microbiological status, data on NF sales, intake assessment,
protein digestibility and DIAAS, genotoxicity and cytotoxicity study.
1 Commission Implementing Regulation (EU) 2017/2469 of 20 December 2017 laying down administrative and scientific
requirements for applications referred to in Article 10 of Regulation (EU) 2015/2283 of the European Parliament and of the
Council on novel foods. OJ L 351, 30.12.2017, pp. 64–71.
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2.2. Methodologies
The assessment follows the methodology set out in the EFSA guidance on NF applications (EFSA NDA
Panel, 2016) and the principles described in the relevant existing guidance documents from the EFSA
Scientific Committee. The legal provisions for the assessment are laid down in Article 11 of Regulation
(EU) 2015/2283 and in Article 7 of the Commission Implementing Regulation (EU) 2017/2469.
This assessment concerns only the risks that might be associated with consumption of the NF
under the proposed conditions of use, and is not an assessment of the efficacy of the NF with regard
to any claimed benefit.
3. Assessment
3.1. Introduction
The NF subject of the application is formulations of Locusta migratoria sp. (migratory locust), an
insect species that belongs to the family of Acrididae. The NF falls under the category ‘food consisting
of, isolated from or produced from animals or their parts’, as described in Article 3 of Regulation (EU)
2015/2283. The NF is produced by farming and processing of L. migratoria and consists mainly of
protein, fat and fibre (dry basis). The NF is proposed to be marketed as frozen, dried or in the form of
powder. The applicant proposes to use the NF as ingredient in various food products such as breakfast
cereals, pasta, bakery products, sauces, meat products and meat imitates. Products with the NF can
be consumed by the general population.
According to Regulation (EU) 2015/2283, this NF falls under the following category:
i) food consisting of, isolated from or produced from animals or their parts, except for animals
obtained by traditional breeding practices which have been used for food production within
the Union before 15 May 1997 and the food from those animals has a history of safe food use
within the Union.
3.2. Identity of the NF
The NF consists of frozen, dried and ground formulations of Locusta migratoria sp. (migratory
locust). The term ‘migratory locust’ refers to the adult of Locusta migratoria, an insect species that
belongs to the Family of Acrididae, Subfamily Locustinae, Genus Locusta. The following scientific
synonyms have been described in Global Biodiversity Information Facility – (GBIF Secretariat, 2019),
Gryllus (Locusta) migratorius Linnaeus 1758; Pachytylus migratorius, Rehn 1902; Gryllus (Locusta)
danicus, Linnaeus 1767; Locusta danica, Ikonnikov 1913; Pachytylus danicus, Doi 1932; Locusta
migratoria Danica, Ju 1969; Gryllus (Locusta) cinerascens Fabricius, 1781; Pachytylus cinerascens,
Walker 1870.
L. migratoria sp. is currently present in various regions worldwide, including Australia, Asia, Africa and
Europe (GBIF Secretariat, 2019). The identity of the insect species has been certified by means of
morphological identification by the applicant in collaboration with certified taxonomist in the Netherlands.
Due to density-dependent phase polyphenism, L. migratoria exists as two phenotypes, solitary and
gregarious. The applicant ensures that adults are reared and harvested during solitary phase by
controlling rearing conditions.
The NF is intended to be marketed as A) blanched and frozen L. migratoria (LM frozen); B)
blanched and freeze-dried L. migratoria (LM dried); C) blanched, freeze-dried and ground L. migratoria
(LM powder). The insects are farmed under controlled rearing conditions.
3.3. Production process
According to the information provided, the NF is produced in line with Hazard Analysis Critical
Control Points (HACCP) principles. The applicant stated that insects were reared at a facility registered
at the Netherlands Food and Consumer Product Safety Authority (NVWA) as food-producing company.
The production process can be divided into three distinct phases, i.e. farming, harvest and post-
harvest processing. All steps take place under controlled rearing conditions.
Farming includes mating of the adult insect population and rearing of the nymphs. The eggs are
separated from the adult insects so that nymphs can consequently grow separately. After being hatched
from the eggs, the nymphs grow under monitored temperature and humidity conditions, in stainless steel
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containers, certified for food contact and regularly disinfected. The applicant reported that no
antimicrobials, veterinary medicinal products or solvents are used during the entire production process.
The applicant reported that the feed used to feed L. migratoria is a plant-derived material
compliant with Directive 2002/32/EC2 and produced according to Good Manufacturing Practice (GMP+).
During farming, L. migratoria can be infected by pathogens, including bacteria, viruses,
entomopathogenic fungi, microsporidia and protists (Eilenberg et al., 2015). Pathogens that may affect
L. migratoria include the virus Cricket iridovirus (CrIV) (Kleespies et al., 1999), the fungus Metarhizium
acridum (Eilenberg et al., 2015) and a microsporidium named Paranosema locustae (Maniania et al.,
2008). Literature review conducted by the applicant highlighted that these pathogens are specific at
species or family level, and non-pathogenic for humans or other vertebrates. An example of food-
borne bacteria to which L. migratoria is sensitive is Bacillus thuringiensis (Song et al., 2008). However,
its potential presence in the NF is monitored by microbiological analysis of Bacillus as reported in
Section 3.4 Table 4. In fact, B. cereus and B. thuringiensis are considered indistinguishable in the
context of clinical diagnostics and food microbiology (EFSA BIOHAZ Panel, 2016).
Adults are harvested (3–5 weeks old) after being separated from the substrate and faeces. Decayed
insects are identified by visual inspection and removed from the rearing batches. After the harvest, a
minimum of 24 h fasting step is implemented to allow the adults to discard their bowel contents.
The post-harvesting processing includes killing of the adults by freezing and storing at –18°C. Three
formulations of the NF are then obtained by processing. The formulation ‘LM frozen’ is obtained after
removing of legs and wings, rinsing in water, blanching in hot water (> 90°C for at least 10 min) and
freezing. The formulation ‘LM dried’ is obtained after removing legs and wings, rinsing in water,
blanching in hot water (> 90°C for at least 10 min) and freeze-drying. The formulation ‘LM powder’ is
obtained after rinsing in water, blanching in hot water (> 90°C for at least 10 min), freeze-drying and
grinding (including legs and wings).
The thermal treatment contributes to the reduction of the microbial load of the NF as well as the
elimination of potentially present viruses, parasites and reduction of enzymatic activity. Dehydration of
the insects takes place in freeze dryers, resulting in a final product with moisture < 5%. Body parts
(i.e. legs and wings) are removed by the manufacturer (LM frozen and LM dried) to reduce the risk of
intestinal constipation that could be possibly caused by ingestion of the large spines on the insect tibia
(FAO, 2013a). The NF LM powder is obtained via mechanical grinding of the insect (with legs and
wings) and sieving to reduce particle size below 1 mm. The formulations of the NF are packed in
hermetically closed packaging and stored at –18°C (LM frozen), or at room temperature (LM dried, LM
powder).
The Panel considers that the production process is sufficiently described.
3.4. Compositional data
In order to confirm that the manufacturing process is consistent and adequate to produce on a
commercial scale a product with certain characteristics, the applicant provided qualitative and
quantitative data on chemical and microbiological parameters for a number of different batches of the
NF formulations i.e. a) LM frozen; b) LM dried; c) LM powder. For all parameters, at least five
independently produced batches were analysed. Considering the production process, the
Panel accepted the view that the two formulations of the NF (LM frozen and LM dried) are
representative of each other regarding the compositional parameters, when the difference in moisture
is taken into account. Where indicated, analyses were performed on LM dried including legs and wings
and considered as representative of LM powder. Microbiological analyses were performed on all
formulations of the NF.
Certificates of accreditation of the laboratories that conducted the analyses were provided by the
applicant. Analytical data were produced using methods validated for other types of matrices.
Whenever in-house methods were employed, a full description of the method as well as results of the
respective validation procedures have been provided.
The NF is a ‘whole food’ as defined by EFSA Scientific Committee (2011), meaning that all its
constituents cannot be fully identified and/or characterised (EFSA NDA Panel, 2016).
The results of the proximate analysis of the NF are presented in Table 1. The amino acid, fatty acid,
vitamin and mineral composition are reported in Section 3.9.
2 Directive 2002/32/EC of the European Parliament and of the Council of 7 May 2002 on undesirable substances in animal feed.
OJ L 140, 30.5.2002, p. 10.
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Table 1: Batch to batch analysis of the NF (LM frozen*, LM dried, LM powder)





(g/100 g of NF)
14.5 14.5 14.5 14.3 14.3 Dumas,
(N 9 6.25)
Fat (g/100 g of
NF)




(g/100 g of NF)




(g/100 g of NF)
2.6 2.6 2.5 2.7 2.5 EC-152/2009
Sugars** (g/100
g of NF)
– – – – – NEN-3571;
EC-152/2009
Ash (g/100 g of
NF)
0.7 0.7 0.9 0.7 0.9 EC-152/2009
Moisture (g/100
g of NF)
71.5 71.5 71.5 71.5 71.5 Gravimetric
method
Energy value
(kJ/100 g of NF)










Parameter (unit) LMDNFD01 LMDNFD02 LMDNFD03 LMDNFD04 LMDNFD05
Crude protein
(g/100 g of NF)
48.7 48.8 48.9 48.1 48.3 Dumas,
(N 9 6.25)
Fat (g/100 g of
NF)




(g/100 g of NF)




(g/100 g of NF)
8.8 8.8 8.3 9.0 8.6 EC-152/2009
Sugars (g/100 g
of NF)
< 0.6 < 0.6 < 0.6 < 0.6 < 0.6 NEN-3571;
EC-152/2009
Ash (g/100 g of
NF)
2.3 2.2 3.1 2.5 3.0 EC-152/2009
Moisture (g/100
g of NF)
4.2 4.3 4.3 4.2 4.4 Gravimetric
method
Energy value
(kJ/100 g of NF)










Parameter (unit) LMGNFD01 LMGNFD02 LMGNFD03 LMGNFD04 LMGNFD05
Crude protein
(g/100 g of NF)
55.7 55.6 57.2 52.5 53.8 Kjeldahl
(N 9 6.25)
Fat (g/100 g of
NF)
35.8 34.2 33.0 38.5 36.8 Gravimetric
method
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The Panel notes that there is a variation of the values of some proximate parameters, but this can
be expected due to analytical variation and since the NF is produced using whole insects. The
compositional values may also depend on the rearing conditions (feed, developmental stage at the
time of harvesting, ambient conditions (Oonincx and van der Poel, 2011; Rumpold and Schl€uter,
2013a).
Regarding the crude protein content of the NF, the Panel notes that Janssen et al. (2017) suggest
that it is possibly overestimated when using the nitrogen-to-protein conversion factor of 6.25, mainly
due to the presence of chitin. This issue will be addressed in detail in Section 3.9.
Chitin is the main form of dietary fibre in L. migratoria (Oonincx and van der Poel, 2011; Hahn
et al., 2018). It is a linear polysaccharide constituted by b-(1,4)-linked 2-amino-2-deoxy-b-D-
glucopyranose and 2-acetamido-2-deoxy-b-D-glucopyranose residues (Roberts, 1992). Due to the
differences in body parts, after EFSA’s request, the applicant provided analytical data on the levels of
chitin in 5 independently produced batches in two formulations of the NF (LM dried and LM powder).
The panel notes that a nationally or internationally recognised reference method for the analytical
determination of chitin does not exist. The chitin content in the NF was based on the protocol
described by Hahn et al. (2018), in which chemical treatment based on Acid Detergent Fibre – Acid
Detergent Lignin is used to estimate the chitin content in different insects. The Panel considers that
the differences between the content of dietary fibre (Table 1) and chitin (Table 2) are due to different
analytical methods utilised.





(g/100 g of NF)




(g/100 g of NF)
7.4 7.6 7.0 6.5 6.6 AOAC
2009.01
Sugars**
(g/100 g of NF)
0.24 0.22 0.23 0.19 0.20 HPAEC-PAD
Ash (g/100 g of
NF)
1.9 1.9 1.9 1.9 1.9 Gravimetric
method
Moisture
(g/100 g of NF)
1.2 1.1 1.2 2.4 1.0 Gravimetric
method
Energy value
(kJ/100 g of NF)






570 550 550 570 560 Regulation
(EU) 1169/
2011
*: Derived by calculation by the applicant from LM dried by considering moisture.
**: Glucose, fructose, lactose, sucrose, maltose; AOAC: Association of Official Agricultural Chemists; HPAEC-PAD: High-
Performance Anion-Exchange Chromatography with Pulsed Amperometric Detection.
Table 2: Chitin content of the Novel Food formulations (LM frozen*, LM dried, LM powder)
LM frozen
Chitin (g/100 g NF) LM frozen 01 LM frozen02 LM frozen03 LM frozen04 LM frozen05
1.77 1.74 1.77 1.80 1.77
LM dried
Chitin (g/100 g NF) LM dried01 LM dried02 LM dried03 LM dried04 LM dried05
6.5 6.4 6.5 6.6 6.5
LM powder
Chitin (g/100 g NF) LM powder01 LM powder02 LM powder03 LM powder04 LM powder05
12.0 12.1 12.1 10.5 11.9
*: Derived by calculation by the applicant from LM dried by considering moisture.
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Levels of heavy metals in LM powder are reported in Table 3. The applicant compared the values to
the maximum levels for other foods as set in Regulation (EC) No. 1881/2006. The Panel notes that the
levels of heavy metals reported for the NF are comparable to those set for other foods, and that in the
current EU legislation, no maximum levels of heavy metals are set for insects as food.
Analytical data on the concentrations of aflatoxins B1, B2, G1, G2, ochratoxin A, nivalenol,
deoxynivalenol, zearalenone, T2- and HT2-toxins and, upon EFSA’s request, fumonisin B1 and
fumonisin B2, were provided (Table 3). Values were compared to maximum limits for different foods
set in EC Regulation (EC) No 1881/2006. The Panel notes that, in the current EU legislation, no
maximum levels of mycotoxins are set for insects as food.
The content of dioxins and dioxins-like compounds were provided by the applicant (Table 3) and
values were compared to maximum levels for other foods as set in Regulation (EC) No 1881/2006).
The Panel notes that in the current EU legislation, no maximum levels of dioxins-like compounds are
set for insects as food.
Analytical data of the pesticide concentrations for five independently produced batches of the NF
have been provided. The results showed that the tested pesticide concentrations in the LM powder are
below the limits of quantification (LOQ) of the implemented method used (GC-MS ITD Equal CEN/TR




LM 01 LM 02 LM 03 LM 04 LM 05
Heavy metals (mg/kg)
Arsenic (As) Internal method,
ICP-MS(a)
0.01 0.01 0.01 < 0.02 0.02
Mercury (Hg) 0.0018 0.0020 0.0012 0.0022 0.0018
Lead (Pb) 0.03 0.04 0.03 0.07 0.06
Cadmium (Cd) 0.04 0.05 0.04 0.05 0.04
Mycotoxins (lg/kg)
Aflatoxins B1 Internal Method,
IAC-LC-FLD(b)
< 0.10 < 0.10 < 0.10 < 0.10 < 0.10
Aflatoxins B2 < 0.04 < 0.04 < 0.04 < 0.04 < 0.04
Aflatoxins G1 < 0.10 < 0.10 < 0.10 < 0.10 < 0.10
Aflatoxins G2 < 0.06 < 0.06 < 0.06 < 0.06 < 0.06
Aflatoxins (Sum of B1, B2, G1, G2) < 0.30 < 0.30 < 0.30 < 0.30 < 0.30
Ochratoxin A Internal Method,
IAC-LC-FLD(b)
< 0.4 < 0.4 < 0.4 < 0.4 < 0.4
Nivalenol Internal Method,
LC-MS/MS(c)
< 20 < 20 < 20 < 20 < 20
Deoxynivalenol < 20 < 20 < 20 < 20 < 20
Zearalenone < 10 < 10 < 10 < 10 < 10
T-2 and HT-2 < 20 < 20 < 20 < 20 < 20




< 0.0073 < 0.0073 < 0.0073 < 0.0073 < 0.0073
Fumonisin B2 < 0.0031 < 0.0031 < 0.0031 < 0.0031 < 0.0031
Dioxins (pg/g fat)




1.0 1.0 1.1 1.3 1.0
*: Analyses performed on LM dried including legs and wings.
(a): ICP-MS = inductively coupled plasma-mass spectrometry.
(b): IAC-LC/FLD = immunoaffinity chromatography-liquid chromatography/fluorescence detector.
(c): LC-MS/MS = liquid chromatography/tandem mass spectrometry.
(d): WHO (2005) PCDD/F+PCB = sum of polychlorinated dibenzo-para-dioxins-polychlorinated dibenzofurans-polychlorinated
biphenyls expressed as World Health Organization toxic equivalent.
(e): GC-MS/MS = gas chromatography/tandem mass spectrometry.
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16468 and LC-MS Equal CEN/TR 15641) and are complying with Regulation (EC) No 396/20053
defining maximum residue limits (MRL) of pesticides in foods.
Given the vegetable origin of the feeding substrate and the absence of prion or prion-related
encoding genes in insects, the development of specific prion diseases due to the consumption of the
NF is not expected (EFSA Scientific Committee, 2015).
The applicant provided analytical data for histamine for five independently produced batches of LM
dried and LM powder (all below 10 mg/kg) and values were compared to the limit of 200 mg/kg for
histamine in fishery products set in Commission Regulation EC No 2073/2005. High concentrations of
putrescine (470–620 mg/kg in LM dried and 279–299 mg/kg in LM powder) were reported. No legal
limit has been established for putrescine in any food although it may accumulate at very high
concentration in cheese (up to 1,560 mg/kg), fermented sausages (up to 1,550 mg/kg) and fish
sauces (up to 1,220 mg/kg) (EFSA BIOHAZ Panel, 2011). A recent study by del Rio et al. (2018)
described a real-time analysis of the cytotoxicity of putrescine and cadaverine on intestinal cell cultures
and found that the LOAEL (lowest observed adverse effect level) for putrescine was 881.50 mg/kg and
for cadaverine 510.89 mg/kg. Formation of biogenic amines can occur by endogenous biosynthesis,
uptake from the feed source and by bacteria of the intestinal microbiota of insects. It can also occur
during food processing and storage as result of bacterial contamination (EFSA BIOHAZ Panel, 2011).
Upon EFSA’s request, the applicant was asked to analyse the NF for Pseudomonas aeruginosa, which
could also be responsible for biogenic amines production. All formulations of the NF were tested and
levels of < 10 cfu/g were reported.
The applicant provided microbiological data on five independently produced batches of all NF
formulations (LM frozen, LM dried, LM powder) (Table 4).
The Panel notes that the applicant did not provide the actual values of the microbiological
parameters, but instead the quantification limits as defined by the dilutions used upon the analyses.
Furthermore, the Panel notes that the microbiological values of the analysed samples do not exceed
the given specification limits.




Units LMPNFD01 LMPNFD02 LMPNFD03 LMPNFD04 LMPNFD05
Total aerobic count (cfu/g) < 1,000 < 1,000 < 1,000 < 1,000 < 1,000
Enterobacteriaceae (cfu/g) < 10 < 10 < 10 < 10 < 10
Escherichia coli (cfu/g) < 10 < 10 < 10 < 10 < 10
Listeria monocytogenes In 25 g ND ND ND ND ND
Salmonella In 25 g ND ND ND ND ND
Bacillus cereus (spores) (cfu/g) < 10 < 10 < 10 < 10 < 10
Coagulase positive
staphylococci
(cfu/g) < 10 < 10 < 10 < 10 < 10
Campylobacter spp. (cfu/g) ND ND ND ND ND
Clostridium perfringens In 25 g < 10 < 10 < 10 < 10 < 10
Yeasts and moulds (cfu/g) < 40 < 10 < 10 < 10 < 10
LM dried (without legs
and wings)
Batch
Units LMDNFD01 LMDNFD02 LMDNFD03 LMDNFD04 LMDNFD05
Total aerobic count (cfu/g) < 1,000 < 1,000 < 1,000 < 1,000 < 1,000
Enterobacteriaceae (cfu/g) < 10 < 10 < 10 < 10 < 10
Escherichia coli (cfu/g) < 10 < 10 < 10 < 10 < 10
Listeria monocytogenes In 25 g ND ND ND ND ND
Salmonella In 25 g ND ND ND ND ND
Bacillus cereus (spores) (cfu/g) < 10 < 10 < 10 < 10 < 10
3 Regulation (EC) No 396/2005 of the European Parliament and of the Council of 23 February 2005 on maximum residue levels
of pesticides in or on food and feed of plant and animal origin and amending Council Directive 91/414/EEC. OJ L 70,
16.3.2005, p. 1.
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The Panel considers that information provided on the composition is sufficient for characterising the
NF.
3.4.1. Stability
The applicant provided data on the microbiological profile of five batches of the novel food (LM
frozen, LM dried), and upon request (LM powder). The applicant proposed a shelf-life of 12 months for
each formulation. The NF formulations have been analysed immediately after manufacturing
(0 months) and after storage at room temperature (LM dried and LM powder) or –18°C (LM frozen) for
12 months. Microbiological data at 3, 6 and 9 months were also provided for LM frozen and LM dried,
and results were within acceptable values between 0 and 12 months. Microbiological data at 6 months
were provided for LM powder, falling within 0–12 months values. The Panel notes that the
microbiological values do not exceed the given specification limits.
Coagulase positive
staphylococci
(cfu/g) < 10 < 10 < 10 < 10 < 10
Campylobacter spp. (cfu/g) ND ND ND ND ND
Clostridium perfringens (cfu/g) < 10 < 10 < 10 < 10 < 10
Yeasts and moulds (cfu/g) < 40 < 10 < 10 < 10 < 10













Total aerobic count (cfu/g) < 40 < 40 < 10 < 10 < 40
Enterobacteriaceae (cfu/g) < 10 < 10 < 10 < 10 < 10
Escherichia coli (cfu/g) < 10 < 10 < 10 < 10 < 10
Listeria monocytogenes In 25 g ND ND ND ND ND
Salmonella In 25 g ND ND ND ND ND
Bacillus cereus (spores) (cfu/g) < 10 < 10 < 10 < 10 < 10
Coagulase positive
staphylococci
(cfu/g) < 10 < 10 < 10 < 10 < 10
Campylobacter spp. (cfu/g) ND ND ND ND ND
Clostridium perfringens (cfu/g) < 10 < 10 < 10 < 10 < 10
Yeasts and moulds (cfu/g) < 10 < 10 < 10 < 10 < 10
cfu: colony forming units; ND: not detected.


























Total aerobic count (cfu/g) < 1,000 < 1,000 < 1,000 < 1,000 < 1,000 < 4,000 < 1,000 < 2,000 < 1,000 < 1,000
Enterobacteriaceae (cfu/g) < 10 < 10 < 10 < 10 < 10 < 10 < 10 < 10 < 10 < 10





ND ND ND ND ND ND ND ND ND ND
Salmonella In 25
g
ND ND ND ND ND ND ND ND ND ND
Bacillus cereus
(spores)
(cfu/g) < 10 < 10 < 10 < 10 < 10 < 10 < 10 < 10 < 10 < 10
Coagulase positive
Staphylococci
(cfu/g) < 10 < 10 < 10 < 10 < 10 < 10 < 10 < 10 < 10 < 10
Clostridium
perfringens
(cfu/g) < 10 < 10 < 10 < 10 < 10 < 10 < 10 < 10 < 10 < 10
Yeasts and moulds (cfu/g) < 40 < 10 < 10 < 10 < 10 < 10 < 10 < 10 < 10 < 10
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After EFSA’s request, the applicant provided analytical data on the water activity and the oxidative
status of the fats in the NF (LM powder) at 6 months (data not shown) and 12 months of shelf-life
(Table 6). Peroxide value (PV), p-anisidine value (PA) and free fatty acids (FFA) have been determined.
Regarding the relatively high p-anisidine value and its variability among batches (1.4–16.4) at t = 0
when compared to data at t = 12 months, the applicant indicated that such variation may be due to
improper handling, packaging and storing of certain packages. The Panel notes that the variation was

























Total aerobic count (cfu/g) < 1,000 < 1,000 < 1,000 < 1,000 < 1,000 < 10 < 10 < 10 < 10 < 10
Enterobacteriaceae (cfu/g) < 10 < 10 < 10 < 10 < 10 < 10 < 10 < 10 < 10 < 10





ND ND ND ND ND ND ND ND ND ND
Salmonella In 25
g
ND ND ND ND ND ND ND ND ND ND
Bacillus cereus
(spores)
(cfu/g) < 10 < 10 < 10 < 10 < 10 < 10 < 10 < 10 < 10 < 10
Coagulase positive
Staphylococci
(cfu/g) < 10 < 10 < 10 < 10 < 10 < 10 < 10 < 10 < 10 < 10
Clostridium
perfringens
(cfu/g) < 10 < 10 < 10 < 10 < 10 < 10 < 10 < 10 < 10 < 10

























Total aerobic count (cfu/g) < 40 < 40 < 10 < 10 < 40 < 10 < 40 < 40 < 10 < 10
Enterobacteriaceae (cfu/g) < 10 < 10 < 10 < 10 < 10 < 10 < 10 < 10 < 10 < 10





ND ND ND ND ND ND ND ND ND ND
Salmonella In 25
g
ND ND ND ND ND ND ND ND ND ND
Bacillus cereus
(spores)
(cfu/g) < 10 < 10 < 10 < 10 < 10 < 10 < 10 < 10 < 10 < 10
Coagulase positive
Staphylococci
(cfu/g) < 10 < 10 < 10 < 10 < 10 < 10 < 10 < 10 < 10 < 10
Clostridium
perfringens
(cfu/g) < 10 < 10 < 10 < 10 < 10 < 10 < 10 < 10 < 10 < 10
Yeasts and moulds (cfu/g) < 10 < 10 < 10 < 10 < 10 < 10 < 10 < 10 < 10 < 10
cfu: colony forming units; ND: not detected.
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Stability in the intended-for-use matrices. Since the NF is going to be used as an ingredient
for the manufacturing of other foods, EFSA asked the applicant to investigate its stability when used as
an ingredient in the intended-for-use matrices (see Section 3.7.2 Proposed uses and use levels). In
particular, the applicant addressed the lipid hydrolysis and oxidation (FFA, PV and PA), the formation of
process contaminants (polycyclic aromatic hydrocarbons - PAH) and microbiological stability of a wet
food matrix composed of thermally processed beans and vegetables with 15% w/w LM frozen. The
shelf-life of the intended-for-use matrix was addressed at t = 0 and t = 12 months.
Free fatty acids were reported in the range of 0.1–2.2% of total fat and 1.3–2.3% of oleic acid in
the product at t = 0 and t = 12 months. Peroxide values of the product were below 0.1 meq/kg fat at
t = 0 and t = 12 months, with one batch at 12 months showing 0.6 meq/kg fat. P-anisidine values in
the products ranged from 14.6–19.8 at t = 0 to 31.7–65.9 at t = 12 months, showing the presence of
secondary oxidation products. After EFSA’s request, the applicant provided the content of p-anisidine in
a control sample at t = 0, being 1.9. Literature reports that highly processed foods (e.g. mayonnaise)
show a direct relation with FFA, PV and PA, especially when high pressure is applied (Sethi et al.,
2017). When comparing the level of p-anisidine of canned vegetables with LM powder at 0 months, it
can be concluded that the food matrix had an impact on the PA value.
The content of polycyclic aromatic hydrocarbons in the tested food at t = 0 was below 2.0 lg/kg,
hence below the tolerable limits of crustaceans, cephalopods, muscle meat of fish, oils and fats, as set
in Regulation (EC) No 1881/2006.
After EFSA’s request, the applicant provided analytical data on the oxidative status of fats (FFA, PV
and PA) and microbiological stability of the NF in meat imitates (80% w/w insect inclusion in dry
matter of meat imitates) at t = 0 and under accelerated conditions (ASL) (80°C for 72 h with a
humidity of about 55–60%). A meat imitate was prepared by mixing LM dried with oats, onions, beet
root, salt, eggs and spices. A control sample was prepared without insects. Further after mixing and
processing, the meat imitate was precooked in sunflower oil before packaging and freezing. Free fatty
acids were reported in the range of 0.9% and 1.0%, respectively, at t = 0 and at ASL, compared to
1.2% in the control sample. Peroxide values were less than 0.1 meq/kg in the meat imitate at t = 0,
2.1 meq/kg in the meat imitate at ASL, and 3.9 meq/kg in the control sample. Values of p-anisidine
were comparable between meat imitate and control at t = 0 (32.3 and 36.9, respectively) whereas it
increased to 69.7 for meat imitate under accelerated conditions. There is no health-based guidance
value or legislative limit for pAV in foods and the parameter is primarily used for quality control.
The Panel considers that the stability of the NF in the intended-for-use-matrices studied is well
characterised and does not raise safety concerns.
The Panel notes that the analytical data regarding the putative formation of contaminants due to
the use of NF as an ingredient in the intended-for-use matrices are limited, and no conclusion can be
drawn due to the absence of proper control samples. The Panel notes that the food items containing
the NF have to comply with existing microbiological criteria for foods as set in Commission Regulation
(EC) No 2073/2005 and benchmark levels of acrylamide in bakery products established by Regulation
(EU) 2017/2158. The Panel could not fully conclude on the stability of the NF based on the submitted
data. However, provided that the specifications are met also at the end of the shelf-life, and that
products containing the NF are compliant with respective legislative limits on process contaminants,
the stability data do not raise safety concerns during the studied 12 months.





































2.4 5.6 2.6 1.0 0.8 1.2 1.3 3.9 2.7 < 0.1
p-anisidine
value
16.4 1.8 1.4 16.1 2.2 1.0 3.7 1.3 < 1.0 1.2
(a): Meq: milliequivalents.
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3.5. Specifications
The specifications of the NF as proposed by the applicant are indicated in Table 7.
The Panel considers that the information provided on the specifications of the NF is sufficient and
does not raise safety concerns.
3.6. History of use of the NF and/or of its source
L. migratoria either collected from the wild or reared in farms is consumed as part of the customary
diet in several non-EU countries worldwide. Human consumption of L. migratoria has largely been
Table 7: Specifications of the NF
Description:
LM frozen: thermally processed, frozen Locusta migratoria (without legs and wings)
LM dried: thermally processed, dried Locusta migratoria (without legs and wings)
LM powder: thermally processed, dried, grinded Locusta migratoria (with legs and wings)
Harvesting phase: solitary (Density-dependent phase polyphenism)
Parameters Unit LM frozen LM dried LM powder
Moisture % w/w 67–73 ≤ 5 ≤ 5
Crude protein (N 9 6.25) % w/w 11–21 43–53 50–60
Fat % w/w 7–13 31–41 31–41
Saturated fatty acids % fat 35–43 35–43 35–43
Digestible carbohydrates % w/w 0.1–2.0 0.1–2.0 1.0–3.5
Dietary fibre % w/w 1.5–3.5 5.5–9.0 5.5–9.0
Chitin % w/w < 2.5 < 11 < 14
Peroxide value Meq O2/kg fat ≤ 5 ≤ 5 ≤ 5
Heavy metals
– Lead mg/kg ≤ 0.07 ≤ 0.07 ≤ 0.07
– Cadmium mg/kg ≤ 0.05 ≤ 0.05 ≤ 0.05
Mycotoxins
Aflatoxins (Sum of B1, B2, G1, G2) lg/kg ≤ 0.3 ≤ 0.3 ≤ 0.3
Deoxynivalenol lg/kg ≤ 20 ≤ 20 ≤ 20
Ochratoxin A lg/kg ≤ 0.4 ≤ 0.4 ≤ 0.4
Processing contaminants
Sum of dioxins and dioxins-like PCBs
UB (WHO2005 PCDD/F-PCB-TEQ)
pg/g fat ≤ 1.2 ≤ 1.2 ≤ 1.2
Microbiological
Total aerobic colony count cfu/g ≤ 105 ≤ 105 ≤ 105
Enterobacteriaceae (presumptive) cfu/g ≤ 100 ≤ 100 ≤ 100
Escherichia coli cfu/g ≤ 50 ≤ 50 ≤ 50












Bacillus cereus (presumptive) cfu/g ≤ 100 ≤ 100 ≤ 100
Coagulase positive Staphylococci cfu/g ≤ 100 ≤ 100 ≤ 100
Sulfite-reducing Anaerobes cfu/g ≤ 30 ≤ 30 ≤ 30
Yeasts and moulds cfu/g ≤ 100 ≤ 100 ≤ 100
ND = not detected (i.e. 0); ADF-ADL = acid detergent fibre–acid detergent lignin; ICP-MS = Inductively Coupled Plasma-Mass
Spectrometry; IAC-LC/FLD = immunoaffinity chromatography-liquid chromatography/fluorescence detector; GC-MS/MS = gas
chromatography/tandem mass spectrometry; LC-MS/MS = Liquid chromatography/tandem mass spectrometry; CFU = colony
forming units; dietary fibre may not include chitin due to different analytical methods, UB = upper bound; WHO-PCDD/F-PCB-
TEQ: sum of polychlorinated dibenzo-para-dioxins-polychlorinated dibenzofurans-polychlorinated biphenyls expressed as World
Health Organization toxic equivalent.
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documented in Madagascar, Cameroun, Congo, Zimbabwe, Sudan, South Sudan, Papua New Guinea,
Thailand, China and Morocco (Jongema, 2017). Species of locusts are considered the most consumed
insect species in Central African Republic (Durst et al., 2010). L. migratoria is commonly consumed as
snack, side dish and in cooking sauces. Their preparation includes frying, roasting, boiling and sun
drying and legs and wings are removed before consumption.
Since 2012, several companies and specialised shops have been selling L. migratoria in the EU
either as whole food or by adding it to other food products. Since the 1 May 2017, L. migratoria is
among the insect species that can be legally introduced in the Swiss market as food, when
commercially reared.
L. migratoria can be found in the Dutch market since 2016.
3.7. Proposed uses and use levels and anticipated intake
3.7.1. Target population
As the NF is intended to be used as an ingredient in standard food categories, the NF can be
consumed by any group of the population. Therefore, the safety data and the exposure assessment
shall cover all population groups (Commission Implementing Regulation (EU) 2017/2469, article 5(6)).
3.7.2. Proposed uses and use levels
The NF formulations (frozen, dried and powder) is proposed to be used as an ingredient in several
food products. These food products are defined using the FoodEx2 hierarchy, and the maximum use
levels are reported in Table 8. The applicant intends to use different formulations of the NF (frozen,
dried, powder) separately in the respective food category, and not in combination.
Table 8: Food categories and maximum use levels intended by the applicant
FoodEx2 level FoodEx2 code Food category
Max use levels (g NF/100 g)
LM frozen LM dried LM powder
L4 A03VD Potato-based dishes 15 5 5
L4 A03VM Legume-based dishes 15 5 5
L4 A03ZN Pizza and pizza-like dishes 15 5 5
L3 A03TE Meat imitates 80 50 50
L4 A0B9X Tomato soup (dry) 20 5 5
L4 A0B9S Mushroom soup (dry) 15 5 5
L4 A0B9R Mixed vegetable soup (dry) 15 5 5
L4 A041P Potato soup 15 5 5
L4 A041M Onion soup 15 5 5
L4 A041Q Legume (beans) soup 15 5 5
L4 A041N Tomato soup 15 5 5
L4 A041R Mushroom soup 15 5 5
L5 A041S Mixed vegetable soup 15 5 5
L3 A01AZ Canned or jarred legumes 20 15 15
L3 A0ETQ Canned/jarred vegetables 20 15 15
L4 A042E Caesar salad 15 5 5
L4 A042H Prepared pasta salad 15 5 5
L2 A03MA Beer and beer-like beverage 2 2 2
L2 A03PM Mixed alcoholic drinks 2 2 2
L2 A04QF Unsweetened spirits and liqueurs 2 2 2
L4 A0EQD Chocolate and similar 30 10 10
L3 A06HL Snacks other than chips and similar 100 100 100
L3 A01BJ Primary derivatives from nuts and
similar seeds
40 20 20
L5 A0BAV Chickpeas (without pods) 40 20 20
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3.7.3. Anticipated intake of the NF
EFSA performed an intake assessment of the anticipated daily intake of the NF based on the
applicant’s proposed uses and maximum use levels (Table 8), using individual data from the EFSA
Comprehensive European Food Consumption Database (EFSA, 2011). The lowest and highest mean
and 95th percentile anticipated daily intake of the NF on a mg/kg body weight (bw) basis, among the
EU dietary surveys are presented in Table 9.
The estimated daily intake of the NF for each population group from each EU dietary survey is
available in the Excel file annexed to this scientific opinion (under supporting information).
3.7.4. Estimate of exposure to undesirable substances
Based on the highest P95 intake estimate (Table 9), EFSA calculated the exposure to undesirable
substances (heavy metals, toxins) for all population groups. The specification limits (Table 7) were
used as maximum concentrations of the undesirable substances. When specification limits for a
substance of possible concern have not been proposed, the maximum values reported for the analysed
batches were used. Consumption of the NF under the proposed uses and use levels does not
contribute substantially to the overall exposure to the analysed undesirable substances through diet.
The risk of intestinal constipation caused by the large spines on the tibia and chitinous material has
been reported (FAO, 2013a) and can be reduced by removing legs and wings, or by reducing the
particle size.
3.8. Absorption, distribution, metabolism and excretion (ADME)
Not relevant.
3.9. Nutritional information
The applicant provided nutritional analyses of the NF formulations which consist mainly of protein,
fat, dietary fibre (mainly chitin) and inorganic matter (LM dried, LM powder); water, protein, fat,
dietary fibre (mainly chitin) and inorganic matter (LM frozen). The energy value of the NF is on
average 690, 2,250 and 2,350 kJ/100 g, respectively, for LM frozen, LM dried and LM powder
(Table 1). Analytical data on the amino acid composition, the fatty acid content, minerals and vitamins
FoodEx2 level FoodEx2 code Food category
Max use levels (g NF/100 g)
LM frozen LM dried LM powder
L3 A014C Tree nuts 40 20 20
L3 A015F Oilseeds 40 20 20
L4 A02QC Frozen yoghurt 15 5 5
L3 A024F Sausages 30 10 10
Table 9: Intake estimates resulting from the use of the NF as an ingredient in the intended food




Mean intake (mg/kg bw per day) P95th intake (mg/kg bw per day)
Lowest(a) Highest(a) Lowest(b) Highest(b)
Infants < 1 0 110 0 316
Young children(d) 1–< 3 27 524 176 1,370
Other children 3–< 10 65 356 244 977
Adolescents 10–< 18 22 226 105 671
Adults(c) ≥ 18 67 197 235 639
bw: body weight.
(a): Intakes are assessed for all EU dietary surveys available in the food comprehensive database on 24/03/2021. The lowest
and the highest averages observed among all EU surveys are reported in these columns.
(b): Intakes are assessed for all EU dietary surveys available in the food comprehensive database on 24/03/2021. The lowest
and the highest P95th observed among all EU surveys are reported in these columns (P95th based on less than 60
individuals are not considered).
(c): Includes elderly, very elderly, pregnant and lactating women.
(d): Referred as ‘toddlers’ in the EFSA food consumption comprehensive database (EFSA, 2011).
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in the NF formulations have been provided for five batches of LM powder (LM dried with legs and
wings).
The NF contains on average 14.4 g crude protein per 100 g LM frozen, 48.6 g crude protein per
100 g LM dried and 55.0 g crude protein per 100 g LM powder, calculated using a protein conversion
factor of 6.25. The Panel notes that the use of the conventional factor overestimates the levels of true
protein content in L. migratoria due to the presence of considerable amounts of non-protein nitrogen
derived mainly from chitin (Boulos et al., 2020). A study provided by the applicant identified a
nitrogen-to-protein conversion factor of 5.31 for LM powder (LM dried with legs and wings). Using this
factor, the protein content of the NF is about 15% lower than considering a conversion factor of 6.25.
For regulatory purposes for nutritional labelling, protein is defined as the total nitrogen measured by
the Kjeldahl method multiplied by a nitrogen-to-protein conversion factor of 6.25 [Regulation (EU) No
1169/2011 on the provision of food information to consumers].
The applicant quantified the amino acids in five batches of the NF according to ISO 13903:2005
and EU 152/2009 (Appendix A). The applicant also analysed the amount of amino acids in g per 100 g
protein of LM powder (LM dried with legs and wings). Results show that in the protein from LM
powder, all essential amino acids including sulfur containing amino acids were present in quantities
similar or higher than the recommended levels by FAO (2013b) (Appendix A). Furthermore, the
applicant conducted a study of the true ileal protein digestibility during transit through the dynamic
in vitro gastrointestinal model (tiny-TIM). Casein was used as a reference protein. The tests were
conducted by an accredited laboratory in accordance with GLP. The nitrogen digestibility was
expressed as a percentage of the total nitrogen intake, including non-protein nitrogen. As result, the
true ileal nitrogen digestibility of LM powder (LM dried with legs and wings) was 55.4%  2.4%,
compared to casein 75.3%  1.4%, indicating that proteins of L. migratoria are less bio-accessible
than casein. Following the recommendation by FAO, 2013b, the protein quality was determined by the
Digestible Indispensable Amino Acid Score (DIAAS), using the reference value of child, adolescent,
adult group (3–10 years). The DIAAS value for LM powder corresponded to 70%, compared to casein
with a DIAAS of 91%. Sulfur amino acids (methionine + cysteine) were the limiting amino acids.
The major fatty acids in LM powder (LM dried with legs and wings) are palmitic acid, stearic acid,
oleic acid, linoleic acid and alpha linolenic acid (Appendix B). On average, saturated, monounsaturated
fats and polyunsaturated fatty acids (linoleic and alpha-linolenic acid) constitute 38.2%, 39.9% and
21.9% of total fatty acids, respectively. Similar fatty acids profile for L. migratoria is reported in
literature (Clarkson et al., 2018). The average trans fatty acid content is 0.4% fat.
The applicant provided analytical data on the levels of some minerals and vitamins (Table 10), and
after EFSA’s request, boron, molybdenum, iodine and selenium. LM powder (LM dried with legs and
wings) contains riboflavin, niacin, pantothenic acid, biotin and cobalamin besides vitamin E and small
amounts of thiamine, folic acid, retinol and vitamin D. It also contains P, Zn, Cu and Mn.
Considering the mean contents reported in Table 10, values reported in the specifications, and the
estimated P95 of exposure to the NF, the Panel notes that none of the existing upper levels for the
analysed micronutrients are expected to be exceeded, for any population groups.
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It has been reported that chitin can be partially digested in the human stomach by the acidic
mammalian chitinase (AMCase) (Paoletti et al., 2009; Muzzarelli et al., 2012). However, Paoletti et al.
(2009) suggested that reduction of chitin intake in western diets may have led to reduced expression
of chitinase genes, thus resulting in loss of catalytic efficacy. The NF contains on average 1.8 g, 6.5 g
and 11.7 g chitin in 100 g LM in frozen, dried and powder formulations, respectively (see Table 2). The
Panel considers that chitin is an insoluble fibre that is not expected to be digested in the small
intestine of humans to any significant degree. It is also rather resistant to microbial fermentation and
therefore assumed to be excreted mainly unchanged. Additionally, the Panel notes that chitin can bind
bivalent minerals (Franco et al., 2004; Anastopoulos et al., 2017) possibly affecting their bioavailability,
as reported for dietary fibres in general (Baye et al., 2017).




LMDNFD01 LMDNFD02 LMDNFD03 LMDNFD04 LMDNFD05
Minerals (mg/100 g)
Calcium ICP-MS 30 31 31 29 31
Copper 3.7 3.7 3.8 3.4 3.8
Iodine** 0.02 0.02 0.02 0.03 0.02
Iron 4.1 4.4 4.2 4.7 4.6
Magnesium 54 54 55 53 55
Manganese 0.33 0.35 0.35 0.33 0.33
Phosphorous 450 450 420 450 460
Potassium 410 490 500 470 460
Selenium** < 0.03 0.04 0.05 < 0.03 < 0.03
Sodium 82 86 91 110 98
Zinc 18 19 19 17 14
Boron** ICP-OES 0.2 0.2 0.1 0.2 0.2




EN 12822:2014 3.29 3.33 3.05 2.81 2.96
Biotin (lg/100 g) LST AB 266.1,
1995
37.9 37.8 30.8 50.1 34.8
Cholecalciferol
(lg/100 g)
EN 12821:2009 < 0.25 (LOQ) < 0.25 (LOQ) < 0.25 (LOQ) < 0.25 (LOQ) < 0.25 (LOQ)
Cobalamin (lg/100 g) AOAC 2008,
91 4
1.21 0.9 0.77 0.62 1.01
Folic acid (lg/100 g) AOAC 2013.13 < 5 (LOQ) < 5 (LOQ) < 5 (LOQ) < 5 (LOQ) < 5 (LOQ)
Methyltetrahydrofolate
(5-MTHF) (lg/100 g)
AOAC 2013.13 15.1 14.7 13 11.4 12
Niacin (mg/100 g) EN 15652:2009 7.17 6.67 7.21 7.03 6.49
Pantothenic acid
(mg/100 g)




EN 14164 0.11 0.47 0.1 0.1 0.1
Retinol (lg/100 g) EN 12823-1
2014
63.9 61.5 71.7 59.6 56.9
Riboflavin (mg/100 g) EN 14152:2003 1.34 1.39 1.42 1.32 1.2
Thiamin (mg/100 g) EN 14122:2003 0.08 0.07 0.08 0.07 0.07
Thiamin HCL
(mg/100 g)
EN 14122:2003 0.1 0.09 0.1 0.09 0.09
*: Analyses performed on LM dried including legs and wings.
**: Analyses performed on LM powder: LOQ: limit of quantification; ICP-MS: Inductively coupled plasma mass spectrometry;
ICP-OES: Inductively coupled plasma atomic emission spectroscopy.
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Insects may contain antinutritional factors (ANFs) such as tannins, oxalates, phytate, hydrogen
cyanide (Jonathan et al., 2012; Shantibala et al., 2014), thiaminases (Nishimune et al., 2000) and
protease inhibitors (Eguchi, 1993). The applicant determined the concentrations of total polyphenols,
tannins, oxalic acid, phytic acid, hydrogen cyanide and trypsin inhibitors in five independently produced
batches of LM powder (LM dried with legs and wings) (Table 11). The reported values in the NF are
comparable to the occurrence levels of these compounds in other foodstuffs (Rao and Prabhavathi, 1982;
Gupta, 1987; Holmes and Kennedy, 2000; Schlemmer et al., 2009; EFSA CONTAM Panel, 2019).
The Panel considers that taking into account the composition of the NF and the proposed
conditions of use, the NF is not nutritionally disadvantageous.
3.10. Toxicological information
Some insect species secrete chemical substances with potentially toxic effects, as part of their
defence mechanisms (Dzerefos et al., 2013; Rumpold and Schl€uter, 2013b). However, regarding
L. migratoria the production of such substances has not been reported in the literature.
Regarding the safety of chitin present in the NF, the applicant referred to EFSA’s scientific opinion
on the safety of ‘chitin-glucan’ as a Novel Food ingredient (EFSA NDA Panel, 2010). However, the
Panel considers that the polymer chitin-glucan cannot be considered as representative of the chitin
derived from L. migratoria.
Potential adverse health effects of chitin may be related to immunological effects. As reviewed by
Komi et al. (2018), chitin has been shown to activate a variety of innate (eosinophils, macrophages)
and adaptive immune cells (IL-4/IL-13 expressing T helper type-2 lymphocytes) and this implies the
potential to promote immunological reactions including hypersensitivity. EFSA identified an article (Niho
et al., 1999) (Japanese language, only abstract available in English) stating that no toxic effects related
to chitin were observed in F344 rats at concentrations up to 5% of chitin in the diet for 13 weeks. No
firm conclusion could be drawn by the Panel since only the abstract was accessible.
The applicant has taken commitment for two toxicity studies to be performed with the aqueous
extract from NF. However, due to the insolubility of the test item only one study assessing cytotoxicity
was performed.
In addition, the applicant provided a study retrieved from literature (Turkez et al., 2014) which
investigates the in vitro genotoxic potential of water soluble extracts of L. migratoria on cultured
human blood cells. Additional publications were also identified by EFSA describing subacute and
subchronic toxicity studies performed in the rat with powdered locust mixed in the diet (up to 13
weeks; Ochiai et al., 2020) or administered by gavage (28 days; Kwak et al., 2020).
3.10.1. Genotoxicity
The genotoxicity study intended to be performed on L. migratoria dried was preceded by solubility
and sterility tests.




LMDNFD01 LMDNFD02 LMDNFD03 LMDNFD04 LMDNFD05
Total polyphenols (%) In house
method
0.48 0.45 0.41 0.44 0.46
Tannin (%) Folin Denis
method
0.5 0.7 0.6 0.6 0.6
Oxalic acid (mg/kg) HPLC, in house
method
< 100*** < 100*** < 100*** < 100*** < 100***
Phytic acid (g/kg) ANAL-10445 1.0 1.3 1.8 1.3 1.1
Hydrogen cyanide
(mg/kg)





< 0.5* < 0.5* < 0.5* < 0.5* < 0.5*
*: Analyses performed on LM dried including legs and wings; HPLC: high performance liquid chromatography.
***: Below detection limit.
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Samples of L. migratoria dried were not soluble in water, DMSO, ethanol and acetone at the lowest
concentration of 10 mg/mL, and no homogenous suspension could be achieved. For testing sterility,
L. migratoria dried was grounded and suspended in sterile water at a concentration of 100 mg/mL.
Bacterial colonies and filamentous fungi were observed in two independent tests. The execution of
in vitro genotoxicity tests was prevented by the lack of solubility of the NF and microbiological
contamination.
Genotoxic potential of aqueous extracts (not further specified) of freeze-dried L. migratoria was
assessed by Turkez et al. (2014) in cultured human lymphocytes by sister chromatid exchange,
chromosome aberration and micronucleus assays. The tests were performed without S9 and were
negative in concentrations up to 1,000 mg/L. However, the Panel notes that this study bears limitations
due to poor reporting regarding the experimental conditions applied and especially the characteristics
of the testing material (water extract) with lack of information of insect rearing and processing
conditions.
The Panel considers that the available data do not allow to conclude on possible genotoxicity of the
NF. Generally, for whole foods, EFSA requests genotoxicity testing with suitable extracts.
The Panel notes that the applicant provided a literature review on the history of human
consumption of the insect species. Since no safety concerns were identified in both history of use of
L. migratoria and compositional data of the NF, the Panel considers that genotoxicity studies are not
needed in this specific case.
3.10.2. Cytotoxicity
A cell toxicity assay was performed testing LM powder on three human cell types (HL60 cells, HeLa
cells and Caco-2 cells). Cell survival was quantified by a colorimetric test to measure mitochondrial
activity in viable cells.
No cytotoxic effect was observed in any concentration of the NF used in the studies up to 250 lg/mL.
3.10.3. Subacute and subchronic toxicity
EFSA identified two papers that provide information on the safety of locust powder after repeated
administrations.
In the study by Kwak et al. (2020), 28 days repeated-dose oral toxicity of freeze-dried L. migratoria
powder was investigated in Sprague-Dawley (SD) rats. Information on insect feed used, rearing
conditions and the terminal procedures (fasting, washing, steam sterilisation and freezing) of
L. migratoria are also described in the paper. No specific composition of the test item was provided in
the study. Authors stated that the study has been conducted in agreement with GLP and according to
the relevant OECD (Organization for Economic Co-operation and Development) guideline (OECD TG407
of 2008). Freeze-dried powder of L. migratoria was administered once a day in distilled water (20 mL/
kg) by gavage at the doses of 750, 1,500 and 3,000 mg/kg to five male and five female rats per
group. Changes in a few haematological or biochemical parameters (i.e. monocytes and basophils,
inorganic phosphorus) have been noted; however, they were of limited magnitude, limited to one sex
and without dose correlation. Statistically significant lower prostate weight (relative and absolute) in
the high dose has been recorded, however, reported to be within the historical biological range and
therefore considered of doubtful biological relevance. The Panel notes that histopathology examination
was limited to liver and kidney (no abnormalities were noted) at all doses tested, while other collected
organs/tissues were not examined even in the high dose group.
The authors concluded that under the experimental conditions applied, the NOAEL (no observed
adverse effect level) was considered the high dose of 3,000 mg/kg bw per day. On the basis of the
information available from the paper and with the limitations noted, the Panel agrees on this
conclusion.
In Ochiai et al. (2020), acute, subacute and subchronic oral toxicity studies were conducted with
powdered L. migratoria5 produced in Thailand. No information was available concerning the insect
rearing conditions and processing to obtain the powder. The L. migratoria powder utilised in this study
contained 75.5% protein, 12.0% fat, 3% ash and 0.5% fibre, compared to the NF specifications
(48.5–63.5% protein, 28–42% fat, 1.3–2.8% ash, 5.5–9.0% fibre). The study was not described as
conducted according to Good Laboratory Practices (GLP), however, it is stated that experimental
procedures applied were following principles of OECD test guidelines (specifically OECD TG 407 and
5 Confirmation of the species received by EFSA from the study author.
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425 of 2008). EFSA noted however that there were several deviations from the OECD guidelines (e.g.
too few animals, only males investigated, no histopathological examination).
In subacute and subchronic toxicological test, six male Wistar rats per group were fed with a diet
containing 0%, 1% and 3% locust powder for 28 and 90 days. Rats were monitored for general signs
of toxicity, body weight, organ weights, haematology and clinical chemistry parameters, lipids in liver
and faeces and short chain fatty acids in cecum content. No histopathologic examinations were
performed. The subacute toxicological experiment showed a decrease in red blood cells and related
parameters at both concentrations of locust powder at the end of the 28 days, but not observed in the
subchronic setting (i.e. the 90 days). The authors considered these differences to be a transient event
as the plasma levels of iron and other parameters were not significantly changed in both experiments.
Glucose in plasma was decreased at 3% locust powder only after 28 days, while insulin in plasma was
reduced at 3% locust powder diet at the end of 90 days. Liver lipid accumulation and faecal fat
excretion increased in the 3% locust powder diet, but were not considered as an adverse effect in
absence of any other toxicologically relevant finding. Gut and cecum content were dose dependently
decreased after 28 and 90 days but was statistically significant only for the gut content relative to
body weight after 28 days ingestion of diet containing 3% locust powder. As highlighted by the
authors, this effect was likely due to enhancement of gastric emptying and intestinal transit. Finally,
cecum short-chain fatty acids were decreased by the locust powder, possibly caused by its increased
fibre and fibre-like components.
The authors concluded that from the subchronic administration the locust powder when mixed up
to 3% in the diet of male rats did not elicit any toxicologically relevant finding. However, considering
the deviations from OECD TG with limited number of animals involved, the use of one sex and the
absence of relevant investigations (e.g. histopathology) no firm conclusions can be drawn by the NDA
Panel.
Although the test items used in the studies described in these papers cannot be considered fully
representative of the NF and in spite of some limitations in the experimental designs and in the
reporting, the Panel considers that these toxicological studies conducted with L. migratoria can be
used as supporting evidence for the safety of the NF and do not raise safety concerns.
3.10.4. Human data
No human studies were provided by the applicant, or retrieved from literature, with the NF or its
source.
3.11. Allergenicity
A literature search has been carried out by the Applicant using Google Scholar and Scopus® to
retrieve relevant data. The relevant information on the source, production process, protein
characterisation, reported case studies for allergenicity due to exposure or consumption of
L. migratoria, immunological studies, cross-reactivity and effect of processing/digestion on allergens
have been reported.
Locusta migratoria (family Acrididae) belongs to the subphylum Hexapoda (class Insecta), one of
the four subphyla of Arthropoda, the others being Crustacea, Myriapoda and Chelicerata. Within
arthropods, several allergens have been reported, including tropomyosin (Reese et al., 1999), arginine
kinase (Binder et al., 2001) and glutathione S-transferase (Galindo et al., 2001). Furthermore,
chitinases, the enzymes that degrade chitin, have been identified as an allergen in some insect species
(Zhao et al., 2015).
Few prevalence studies on food allergy related to insects, mainly for Asian populations, are
available (China and Laos) (Ji et al., 2009; Barennes et al., 2015). Sokol et al. (2017) registered two
events of anaphylaxis due to ingestion of chapulines (roasted grasshopper from Oaxaca, Mexico) in
patients allergic to crustaceans who had no previous exposure to grasshoppers. According to Ji et al.
(2009), ingestion of insects was the cause of 18% anaphylactic food-related reactions in China from
1980 to 2007, and locusts accounted for 27 cases out of 358. Furthermore, the occurrence of
anaphylactic reactions due to fried insects (grasshoppers and crickets) has also been registered in
Thailand (Piromrat et al., 2008).
Multiple allergens have been found in L. migratoria extracts of different molecular weight (Tee
et al., 1988; Lopata et al., 2005; Ji et al., 2009) using different approaches. By using a proteomic and
bioinformatic approach, Barre et al. (2021) identified 73 proteins in L. migratoria, corresponding to
pan-allergens which develop cross-reactivity with other homologous proteins present in arthropods
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(house dust mites and crustaceans), followed by allergens from molluscs and nematodes. These
include arginine kinase, chitinase, glutathione S-transferase, HSP 70, hexamerin, serine protease,
tropomyosin and trypsin. Tropomyosin appeared as a major pan-allergen largely distributed among
dust mites, insects, crustaceans and molluscs, as also confirmed by Sokol et al. (2017).
Cross-reactivity to L. migratoria protein extracts has been evidenced by immunoblotting in sera
from crustaceans and house dust mite allergic individuals (Pali-Sch€oll et al., 2019a) and in sera from
shrimp allergic individuals (Broekman et al., 2017). The main reason for cross-reactivity is the high
protein homology between phylogenetically related organisms, being evident not only between species
within the same subphylum, but also between species from different arthropod subphyla. It includes
crustacean species (e.g. shrimp, crab), chelicerates (e.g. mites) and several insect species (Santos
et al., 1999; Binder et al., 2001; Galindo et al., 2001; Liu et al., 2009; Lopata et al., 2010; Verhoeckx
et al., 2014; Van Broekhoven et al., 2016; Rouge and Barre, 2017; Broekman et al., 2017; De Gier and
Verhoeckx, 2018).
In addition, food processing per se may also have an influence on allergenicity, and this applies to
insect allergens as well, although the effect of food processing on allergenicity cannot be predicted
(EFSA NDA Panel, 2014). Pali-Sch€oll et al. (2019b) reported that some processing treatments, such as
enzymatic hydrolysis or thermal treatments reduced the IgE binding from crustacean and mite allergic
patients to L. migratoria (immunoblotting and skin prick test). de Gier and Verhoeckx (2018) reported
a review of the literature on the effect of thermal processing on allergenicity of several insect proteins
and concluded that it did not eliminate insect protein allergenicity.
Additional aspects should be taken into consideration depending on the feed substrate used to rear
L. migratoria, as it might include common allergenic foods. The applicant reported that a plant-based
substrate containing gluten was used as feed, hence traces of gluten may be found in the insects’ gut.
The Panel notes that changes in the feed can possibly introduce additional allergens, including allergens
which require mandatory labelling according to Annex II of Regulation (EU) No 1169/2011, since traces
of the allergens may remain in the gut of L. migratoria despite implementing a fasting step.
A frequently reported case of allergic symptoms to insects, including L. migratoria, relates to
occupational exposure (Burge et al., 1980; Tee et al., 1988; Lopata et al., 2005).
The Panel considers that the consumption of the NF might trigger primary sensitisation to
L. migratoria proteins. The Panel also considers that allergic reactions may occur in subjects allergic to
crustaceans, mites and molluscs (cross-reactivity). Furthermore, Panel notes that additional allergens
may end up in the NF, if these allergens are present in the substrate fed to the insects.
4. Discussion
The NF which is the subject of the application is migratory locust (Locusta migratoria), frozen
without legs and wings, dried without legs and wings, or in the form of powder (with legs and wings).
The production process is sufficiently described and does not raise safety concerns. The
Panel considers that the NF is sufficiently characterised. The NF consists mainly of protein, fat, dietary
fibre (mainly chitin) and inorganic matter (LM dried and LM powder); water, protein, fat, dietary fibre
(mainly chitin) and inorganic matter (LM frozen). The concentrations of contaminants in the NF depend
on the occurrence of these substances in the insect feed. Provided that applicable EU legislation
regarding feed is followed, the consumption of the NF does not raise safety concerns. The Panel notes
that there are no safety concerns regarding stability if the NF complies with the proposed specification
limits during its entire shelf life.
The applicant intends to market the NF as an ingredient in several food products. The target
population is the general population. Intake was estimated based on the use of the NF as an
ingredient in the intended food categories at the maximum proposed levels across surveys in the EFSA
Comprehensive European Food Consumption Database. The highest intake estimate was calculated for
young children (1–< 3 years old) ranging from 176 to 1370 mg NF/kg bw per day at the 95th
percentile of the intake distribution. The Panel notes that consumption of the NF under the proposed
uses and use levels does not contribute substantially to the total dietary exposure to the analysed
undesirable substances.
The Panel notes that the dried formulations of the NF have a high protein content, although the
true protein levels in the NF are overestimated due to the presence of non-protein nitrogen of chitin
when using the conversion factor of 6.25. The true ileal nitrogen digestibility of the NF LM powder (LM
dried with legs and wings) is 55.4%  2.4%, with a DIAAS value of 70%. The limiting amino acids
were the sulfur-containing ones. None of the existing upper levels for the analysed micronutrients are
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exceeded considering the proposed uses and use levels. The reported concentrations of the
antinutritional factors in the NF are comparable to those in other foodstuffs. The Panel considers that
the main type of fibre in the NF, chitin, is an insoluble fibre not expected to be digested in the small
intestine of humans to any significant degree and is assumed to be excreted mainly unchanged.
Additionally, the Panel notes that chitin, like other fibres, can possibly affect the bioavailability of
minerals. The Panel notes that, taking into account the composition of the NF and the proposed
conditions of use, consumption of the NF is not nutritionally disadvantageous. Considering that no
adverse effects were observed in the toxicological studies available in the literature on L. migratoria,
the history of use of the NF and its source, the Panel considers that there are no safety concerns.
The Panel considers that the consumption of the NF might trigger primary sensitisation to
L. migratoria proteins. The Panel also considers that allergic reactions may occur in subjects allergic to
crustaceans, mites and molluscs (cross-reactivity). Additionally, the Panel notes that allergens from the
feed (e.g. gluten) may be present in the NF.
5. Conclusions
The Panel concludes that the NF is safe under the proposed uses and use levels. In addition, the
Panel notes that allergic reactions are likely to occur.
5.1. Protection of Proprietary data in accordance with Article 26 of
Regulation (EU) 2015/2283
The Panel could not have reached the conclusion on the safety of the NF under the proposed
conditions of use without the data claimed as proprietary by the applicant (description of the
production process, analytical data on the composition of the NF, analytical data on contaminants in
the NF, stability and microbiological status, data on NF sales, intake assessment, protein digestibility
and DIAAS, genotoxicity and cytotoxicity study).
6. Recommendation
The Panel recommends that research should be undertaken on the allergenicity to Locusta
migratoria, including cross-reactivity to other allergens.
7. Steps taken by EFSA
1) On 09/08/2019 EFSA received a letter from the European Commission with the request for a
scientific opinion on the safety of whole and ground grasshoppers (Locusta migratoria) as a
novel food Ref. Ares(2019)5172695.
2) On 09/08/2019, a valid application on whole and ground grasshoppers (Locusta migratoria),
which was submitted by Fair Insects BV (A Protix Company), was made available to EFSA by
the European Commission through the Commission e-submission portal (NF 2018/0803) and
the scientific evaluation procedure was initiated.
3) On 31/08/2020, EFSA requested the applicant to provide additional information to
accompany the application and the scientific evaluation was suspended.
4) On 21/09/2020, additional information was provided by the applicant through the
Commission e-submission portal and the scientific evaluation was restarted.
5) On 16/11/2021, EFSA requested the applicant to provide additional information to
accompany the application and the scientific evaluation was suspended.
6) On 16/01/2021, additional information was provided by the applicant through the
Commission e-submission portal and the scientific evaluation was restarted.
7) On 12/02/2021, EFSA requested the applicant to provide additional information to
accompany the application and the scientific evaluation was suspended.
8) On 13/04/2021, additional information was provided by the applicant through the
Commission e-submission portal and the scientific evaluation was restarted.
9) On 20/04/2021, EFSA received a letter from the European Commission with the revised
request for a scientific opinion on frozen and dried formulations from migratory locust
(Locusta migratoria) as a novel food.
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10) During its meeting on 25/05/2021, the NDA Panel, having evaluated the data, adopted a
scientific opinion on the safety of frozen and dried formulations from migratory locust
(Locusta migratoria) as a NF pursuant to Regulation (EU) 2015/2283.
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Abbreviations
ADME absorption, distribution, metabolism and excretion
AMCase acidic mammalian chitinase
ANF antinutritional factors
ASL accelerated conditions
BIOHAZ EFSA Panel on Biological Hazards
bw body weight
CFU Colony Forming Units
CONTAM EFSA Panel on Contaminants in the Food Chain
CrIV cricket iridovirus
DIAAS digestible indispensable amino acid score
DMSO dimethyl sulfoxide
FAO Food and Agriculture Organization
FFA free fatty acids
GC-MS/MS gas chromatography coupled mass spectrometry
GLP Good Laboratory Practices
GMP Good Manufacturing Practice
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HACCP hazard analysis critical control points
IAC-LC/FLD immunoaffinity chromatography-liquid chromatography/fluorescence detector
ICP-MS inductively coupled plasma-mass spectrometry
ICP-OES inductively coupled plasma atomic emission spectroscopy
IgE immunoglobulin E
LC-MS/MS liquid chromatography/tandem mass spectrometry
LM Locusta migratoria
LOAEL lowest observed adverse effect level
LOQ limits of quantification
MRL maximum residue limits
NDA EFSA Panel on Nutrition, Novel Foods and Food Allergens
NF novel food
NOAEL no observed adverse effect level
NVWA Dutch Food and Consumer Product Safety Authority
OECD Organization for Economic Co-operation and Development
PA P-anisidine value





sum of polychlorinated dibenzo-para-dioxins-polychlorinated dibenzofurans-
polychlorinated biphenyls expressed as World Health Organization toxic equivalent
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Histidine1 26.3 26.2 25.9 26.8 26.5 26.4 15
Isoleucine1 44.4 44.7 44.7 44.5 43.9 44.4 30
Leucine1 85.6 85.8 85.5 85.6 85.6 85.6 59
Lysine1 55.7 56.4 57.9 56.9 54.7 56.3 45
Methionine1 14.9 14.9 15.3 15.1 14.5 14.9 223
Phenylalanine1 33.0 33.0 33.7 33.0 31.8 32.9 384
Threonine1 39.9 41.3 42.3 41.3 40.7 41.1 23
Tryptophan2 10.6 10.4 9.8 10.5 10.2 10.3 6
Valine1 70.4 69.8 69.7 70.2 71.4 70.3 39
Conditionally essential
Arginine1 59.1 59.4 60.2 59.0 58.8 59.3
Cysteine +
cystine1
8.3 8.2 7.7 8.2 8.0 8.1
Glycine1 69.8 69.5 68.4 69.8 69.8 69.5
Proline1 73.1 73.8 69.1 71.4 75.5 72.6
Tyrosine1 53.1 53.7 52.7 53.0 54.0 53.3
Alanine1 127.7 127.6 125.4 128.0 134.1 128.6
Aspartic acid1 84.5 82.9 85.7 84.4 81.7 83.8
Glutamic acid1 103.2 100.9 104.3 101.4 98.2 101.6
Serine1 40.3 41.5 41.7 40.8 40.5 41.0
*: Analyses performed on LM dried including legs and wings.
1: Method ISO 13903:2005.
2: Method EU 152/2009.
3: Methionine + cysteine.
4: Phenilalanine + tyrosine.
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Appendix B – Fatty acid profile of major fatty acids (% fatty acids) in LM
powder*
Fatty acids LMDNFD01 LMDNFD02 LMDNFD03 LMDNFD04 LMDNFD05
Palmitic acid 28.1 28.5 28.0 28.8 29.2
Stearic acid 7.1 7.1 7.2 7.3 7.2
Oleic acid 36.9 37.4 36.8 39.5 38.5
Linoleic acid 11.8 11.3 11.9 8.9 9.8
Alpha- linolenic acid 11.2 11.0 11.2 10.7 10.8
Saturated fatty acid 37.9 38.0 37.8 38.8 38.7
MUFA 39.0 39.5 38.9 41.5 40.5
PUFA 23.1 22.4 23.3 19.7 20.8
Omega 3 11.3 11.1 11.3 10.8 10.9
Omega 6 11.8 11.3 12.0 8.9 9.8
Trans Fatty acids 0.4 0.4 0.4 0.4 0.4
*: Analyses performed on LM dried including legs and wings.
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Annex A – Dietary exposure estimates to the Novel Food for each
population group from each EU dietary survey
Information provided in this Annex is shown in an Excel file (downloadable at https://efsa.onlinelib
rary.wiley.com/doi/10.2903/j.efsa.2021.6667#support-information-section).
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